Patent · US Active

Aminosteroids for the treatment of a PTP1B associated disease

US11434257B2 · kind B2 · utility

0Cited by
5References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2020
Grant dateSep 6, 2022
Priority date
Expiry dateJan 30, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.